FDLI 2026: FDA Leaders to Discuss Strategic Priorities

Key Takeaways

• The 2026 Food and Drug Law Institute (FDLI) Annual Conference will take place May 6-7, 2026, in Washington, DC.
• The conference will focus on the U.S. Food and Drug Administration's (FDA) strategic priorities, as presented by the FDA Commissioner and Center Directors.
• Over 30 breakout sessions will cover a range of legal, regulatory, compliance, and policy issues.
• Attendees will have opportunities to network with professionals from industry, government, and advocacy organizations.

The 2026 FDLI Annual Conference will be held May 6-7, 2026, at the Ronald Reagan Building and International Trade Center in Washington, DC. This hybrid event will focus on current and emerging issues in food and drug law and regulation, offering both in-person and remote participation options.

The FDLI Annual Conference is a significant event for professionals in the food and drug law sector. It provides a platform to discuss regulatory challenges, share insights, and network with key stakeholders. The 2026 conference promises to address pressing issues and offer valuable learning opportunities.

Highlighted Sessions

The conference will feature sessions with the FDA Commissioner, Chief Counsel, and Center Directors, providing attendees with direct insights into the agency's priorities and perspectives. One confirmed session, titled "AI, Devices, and Drug Development: Model Behavior in Medical Products," will be presented by Sarah Thompson Schick from Reed Smith.

A panel discussion, "Remote, Risk-Based and ’Round the World: FDA Inspections Reimagined," moderated by Laura Akowuah (Cooley), will explore the FDA's evolving inspection approaches, including risk-based targeting, remote assessments, and global oversight.

Networking and Learning

Attendees will have the opportunity to learn from over 100 officials and experts in the field. The conference facilitates networking among industry representatives, government officials, and advocacy professionals, fostering collaboration and knowledge sharing.

Frequently Asked Questions

• When and where will the 2026 FDLI Annual Conference take place?

  The conference is scheduled for May 6-7, 2026, at the Ronald Reagan Building and International Trade Center in Washington, DC.

• What is the format of the event?

  The event will be hybrid, offering both in-person and remote participation options.

• What topics will be covered at the conference?

  The conference will cover current and emerging issues in food and drug law and regulation, including FDA strategic priorities, AI in medical product development, and reimagined FDA inspections.

• Who are some of the speakers and moderators?

  Speakers include the FDA Commissioner, Chief Counsel, and Center Directors. Sarah Thompson Schick (Reed Smith) and Laura Akowuah (Cooley) are confirmed session leaders.

• How can I network at the conference?

  The conference provides numerous opportunities to network with industry, government, and advocacy professionals.

References

1. 2026 FDLI Annual Conference Sponsorship Opportunities
2. FDLI 2026 Annual Conference Overview
3. Reed Smith Event: The Food and Drug Law Institute's (FDLI) Annual Conference
4. Cooley Event: Food and Drug Law Institute (FDLI) Annual Conference

Related coverage

• Sanofi pipeline pdf: Dupixent, Lantus and 2026 catalysts
• Eli Lilly pipeline and deals: GLP-1, vaccines, and 2026 outlook
• Eli Lilly raises 2026 revenue guidance on Mounjaro demand